Prostate Cancer Treatment Pathway
Nemics a common path.
Prostate cancer treatment pathway. One signaling pathway with substantial therapeutic potential in prostate cancer is the pi3k akt mtor pathway. Pathway maps are developed based on evidence from clinical practice guidelines. This pathway map provides an overview of best practices for the management of patients in ontario during specific phases of the prostate cancer continuum. Cutting off the supply of testosterone may cause cancer cells to die or to grow more slowly.
Prostate cancer cells rely on testosterone to help them grow. Prostate cancer is the most common cancer among men after skin cancer but it can often be treated successfully. Prostate cancer pathway map. Document implementing a timed oesophago gastric cancer diagnostic pathway.
If you have prostate cancer or are close to someone who does knowing what to expect can help you cope. The diagnostic pathway has been developed by leading urology teams at uclh the christie and royal marsden cancer vanguards brought together by nhs england and supported by prostate cancer uk. Information about prostate cancer assessment and treatment in saskatchewan. This handbook sets out how the 28 day standard can be achieved for prostate cancer patients in preparation for full monitoring against the standard from april 2020.
Patient booklet the 12 page booklet prostate cancer. Erectile dysfunction can result from prostate cancer or its treatment including surgery radiation or hormone treatments. Here you can find out all about prostate cancer including risk factors symptoms how it is found and how it is treated. Hormone therapy is treatment to stop your body from producing the male hormone testosterone.
Diagnosis and treatment information for patients provides an overview of what to expect and some options available. Prostate cancer videos offering support and advice from people who have been through cancer. Hormone therapy options include. Pathfinder prostate cancer research register a national online register for participating in research into improving the health and lives of people post prostate cancer treatment.
Genomic biomarker based treatment for solid tumours liver cancers lung cancer metastatic malignant disease of unknown primary origin ovarian cancer pancreatic cancer prostate cancer renal cancer sarcoma skin cancer.